Publicación:
Síndrome de disfunción cognitiva de perros geriátrico

Vista sencilla de ítem
dc.contributor.authorGallego, Dianaspa
dc.contributor.authorFigueroa, Judithspa
dc.contributor.authorOrozco, Camilospa
dc.date.accessioned2010-09-01 00:00:00
dc.date.accessioned2022-07-01T20:59:01Z
dc.date.available2010-09-01 00:00:00
dc.date.available2022-07-01T20:59:01Z
dc.date.issued2010-09-01
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.21897/rmvz.313
dc.identifier.eissn1909-0544
dc.identifier.issn0122-0268
dc.identifier.urihttps://repositorio.unicordoba.edu.co/handle/ucordoba/5534
dc.identifier.urlhttps://doi.org/10.21897/rmvz.313
dc.language.isospaspa
dc.publisherUniversidad de Córdobaspa
dc.relation.bitstreamhttps://revistamvz.unicordoba.edu.co/article/download/313/381
dc.relation.citationeditionNúm. 3 , Año 2010 : Revista MVZ Córdoba volumen 15(3) Septiembre-Diciembre 2010spa
dc.relation.citationissue3spa
dc.relation.citationvolume15spa
dc.relation.ispartofjournalRevista MVZ Córdobaspa
dc.relation.referencesNeilson J, Hart B, Cliff K, Ruehl W. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. JAVMA 2001; 218(11):1787-1791. http://dx.doi.org/10.2460/javma.2001.218.1787spa
dc.relation.referencesHead E, Zicker S. Nutraceuticals, aging, and cognitive dysfunction. Vet Clin North Am Small Anim Pract 2004; (34):217-228.spa
dc.relation.referencesLandsberg G. Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(3):471-479. http://dx.doi.org/10.1016/j.pnpbp.2004.12.012spa
dc.relation.referencesRuehl WW, Bruyette DS, DePaoli A, Cotman CW, Head E, Milgram NW, Cummings BJ. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to l-deprenyl therapy. Prog Brain Res 1995; (106):217-225.spa
dc.relation.referencesZicker S. Cognitive and behavioral assessment in dogs and pet food market applications. Prog Neuropsycho Biol Psychiatry 2005; (29): 455-459.spa
dc.relation.referencesPérez-guisado J. El Síndrome de disfunción cognitiva en el perro. Disponible en. RECVET [en línea] 2007 [fecha de acceso 05 de junio de 2009]; 2(01-04). URL disponible en: http://www.veterinaria.org/revistas/recvet/n01a0407/01a040701.pdf.spa
dc.relation.referencesBorras D, Ferrer I, Pumarola M. Age-related Changes in the Brain of the Dog. Vet Pathol 1999; 36(3):202-211. http://dx.doi.org/10.1354/vp.36-3-202spa
dc.relation.referencesHead E. Brian aging in dogs: Parallels with human brain aging and Alzheimer's disease. Vet Ther 2001; 2(3):247-260.spa
dc.relation.referencesKoppang N. Canine ceroid lipofuscinososis-a model for human neuronal ceroid lipofuscinososis and aging. Mech Ageing Dev 1973; (2):421-445.spa
dc.relation.referencesShettleworth SJ. Animal cognition and animal behaviour. Anim Behav 2001; 61(2):277-286. http://dx.doi.org/10.1006/anbe.2000.1606spa
dc.relation.referencesBoutet I, Ryan M, Kulaga V, McShane C, Christie LA, Freedman M, Milgram NW. Age-associated cognitive deficits in humans and dogs: a comparative neuropsychological approach. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(3):433-441. http://dx.doi.org/10.1016/j.pnpbp.2004.12.015spa
dc.relation.referencesWang X, Ding H. Alzheimer's disease: epidemiology, genetics, and beyond. Neurosci Bull 2008; 24(2):105-109. http://dx.doi.org/10.1007/s12264-008-0105-7spa
dc.relation.referencesOsella M, Re G, Odore R, Girardi C, Badino P, Barbero R, et.al. Canine cognitive dysfunction syndrome: Prevalence, clinical signs and treatment with a neuroprotective Natraceutical. Appl Anim Behav Sci 2007; (105):297-310.spa
dc.relation.referencesFrank D. Cognitive dysfunction in dog. In: Hill's European Symposia on Canine Brain Ageing [en línea] 2002. [fecha de acceso 27 de mayo de 2009]. URL disponible en: http://www.ivis.org/proceedings/Hills/brain/frank.pdf?LA=1.spa
dc.relation.referencesRofina JE, van der Meer I, Goossens M, Secrève M, Ederen van AM, Schilder M, et.al. Preliminary inquiry to assess behavior changes in aging pet dogs. En: Bely M, Apathy A editores. Amyloid and Amyloidosis IX; Budapest, Hungary: Apathy A editores; 2001.spa
dc.relation.referencesPeinado MA, del Moral ML, Esteban FJ, Martínez Lara E, Siles E, Jiménez A, et.al. Envejecimiento y neurodegeneración: bases moleculares y celulares. Rev Neurol 2000; 31(11):1054-1065.spa
dc.relation.referencesLandsberg G, Ruehl W. Geriatric behavioral problems. Vet Clin North Am Small Anim Pract 1997; 27(6):1537-1559. http://dx.doi.org/10.1016/S0195-5616(97)50138-0spa
dc.relation.referencesCummings BJ, Su JH, Cotman CW, White R, Russell M. b-Amyloid accumulation in aged canine brain. A model of early plaque formation in Alzheimer's disease. Neurobiol Aging 1993; (14):547-556.spa
dc.relation.referencesGerosa R. Geriatría canina: trastornos y lesiones orgánicas en perros de edad avanzada. Buenos Aires: Ed Interamerica; 2007.spa
dc.relation.referencesAssociation AVM. US Pet Ownership & Demographics Sourcebook. Schaumburg, Illinois: American Veterinary Medical Association; 1997.spa
dc.relation.referencesPérez J. La descripción de los ovillos neurofibrilares en la enfermedad de Alzheimer. Rev Esp Patol 2007; (40)1:60-65.spa
dc.relation.referencesCummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ, et.al. Diffuse plaques contain C-terminal Ab 42 and not Ab 40: evidence from cats and dogs. Neurobiol Aging 1996; 17(4):653-659. http://dx.doi.org/10.1016/S0197-4580(96)00062-0 http://dx.doi.org/10.1016/0197-4580(96)00062-0spa
dc.relation.referencesPugliese M, Gangitano C, Ceccariglia S, Carrasco J, Rodríguez M, Michetti F, et.al. Canine cognitive dysfunction and the cerebellum: Acetylcholinesterase reduction, neuronal and glial changes. Brain Res Rev 2007; (1139):85-94.spa
dc.relation.referencesWalker LC: Animal models of cerebral beta-amyloid angiopathy. Brain Res Rev 1997; (25):70-84.spa
dc.relation.referencesGaldzicki Z, Fukuyama R, Wadhwani K, Rapoport S, Ehrenstein G. b-Amyloid increases choline conductance of PC12 cells: Possible mechanism of toxicity in Alzheimer's disease. Brain Res Rev 1994; (646): 332-336.spa
dc.relation.referencesKiatipattanasakul W, Nakamura S, Hossain M, Nakayama H, Uchino T, Shumiya S, et al. Apoptosis in the aged dog brain. Acta Neuropathol 1996; (92):242-248.spa
dc.relation.referencesSu JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuro Report 1994; (5):2529-2533.spa
dc.relation.referencesRofina JE, Singh K, Skoumalova-Vesela A, van Ederen AM, van Asten AJ, Wilhelm J, et al. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine. Amyloid 2004; 11(2):90-100. http://dx.doi.org/10.1080/13506120412331285779spa
dc.relation.referencesDimakopoulos A, Mayer R. Aspects of Neurodegeneration in the Canine Brain. J Nutr 2002; 132(Supl 1):1579-1582.spa
dc.relation.referencesHead E, Callahan H, Muggenburg BA, Cotman CW, Milgram NW. Visual-discriminación learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging 1998; 19(5):415-425. http://dx.doi.org/10.1016/S0197-4580(98)00084-0spa
dc.relation.referencesColle MA, Hauw JJ, Crespeau F, Uchiara T, Akiyama H, Checler F, et al. Vascular and parenchymal Ab deposition in the aging dog: correlation with behavior. Neurobiol Aging 2000; (21):695-704.spa
dc.relation.referencesAmes BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; (90):7915-7922.spa
dc.relation.referencesHead E. Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging. Neurochem Res 2009; (34): 670-678.spa
dc.relation.referencesCotman C, Head E, Muggenburg B, Zicker S, Milgram N. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol Aging 2002; (23):809-818.spa
dc.relation.referencesKiatipattanasakul W, Nakamura S, Kuroki K, Nakayama H, Doi K. Immunohistochemical detection of anti-oxidative stress enzymes in the dog brain. Neuropathology 1997; (17):307-12.spa
dc.relation.referencesLieberman D, Mody I, Pike C, Cotman C. â-Amyloid (25-35) prolongs opening of NMDA channels through an intracellular pathway. Soc Neurosci 1994; (20):602.spa
dc.relation.referencesAdams B, Chan A, Callahan H, Siwak C, Tapp D, Ikeda-Douglas C, et al. Spatial learning and memory in the dog as a model of cognitive aging. Behav Brain Res 2000; 108(1):47-56. http://dx.doi.org/10.1016/S0166-4328(99)00132-1spa
dc.relation.referencesMilgram NW, Head E, Weiner E, Thomas E. Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci 1994; (108):57-68.spa
dc.relation.referencesUchino T, Kida M, Baba A, Ishii K, Okawa N, Hayashi Y, Shumiya S. Senile dementia in aged dogs and the diagnostic standards. Proceedings of the 17th Symposium of Japan Society for Biomedical Gerontology. Biomed Gerontol 1995; (19):24-31.spa
dc.relation.referencesPageat P. Description, clinical and histological validation of the A.R.C.A.D. score (evaluation of age-related cognitive and affective disorders). En: Lynne Seibert DVM, MS editors. Newsletter of the American Veterinary Society of Animal Behavior. Third International Congress on Behavioural Medicine; Boston 7-8 de Agosto de 2001. Boston: Lynne Seibert DVM, MS editors; 2001.spa
dc.relation.referencesCampbell S, Trettien A, Kozan B. A non comparative open-label study evaluating the effect of selegiline hydrocloride in a clinical setting. Vet Ther 2001; (2):24-39.spa
dc.relation.referencesLandsberg G. Decline in Senior Pets Therapeutic Options for Cognitive. J Am Anim Hosp Assoc 2006; 42: 407-413. http://dx.doi.org/10.5326/0420407spa
dc.relation.referencesHead E, Liu J, Hagen T, Muggenburg B, Milgram N, Ames B, Cotman C. Oxidative damage increases with age in a canine model of human brain aging. J Neurochem 2002; (82): 375-381.spa
dc.relation.referencesLauner LJ, Andersen K, Dewey M, Lettenneur L, Ott A, Amaducci L. Rates and risk factors for dementia and Alzheimer's disease. Results from EURODEM pooled analyses. Neurology 1999; (52):78-74.spa
dc.relation.referencesShimazawa M, Chikamatsu S, Morimoto N, Mishima S, Nagai H, Hara H. Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage. Ecam 2005; 2(2):201-207.spa
dc.relation.referencesLiu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci USA 2002; 99(4):1876-1881. http://dx.doi.org/10.1073/pnas.261709098 http://dx.doi.org/10.1073/pnas.261709299spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistamvz.unicordoba.edu.co/article/view/313spa
dc.subjectCanine cognitive dysfunctionspa
dc.subjectcanine agingspa
dc.subjectneurodegenerationspa
dc.subjectcanine dementia syndromespa
dc.titleSíndrome de disfunción cognitiva de perros geriátricospa
dc.title.translatedSíndrome de disfunción cognitiva de perros geriátricoeng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication
Archivos
Colecciones
HAJ. Revista MVZ